RESMETIROM: AN UPDATE ON THERAPY FOR METABOLIC DYSFUNCTION-ASSOCIATED STEATOHEPATITIS (MASH)

Descargar Publicación
AISF practice guidance on pharmacological treatment of metabolic-dysfunction associated steatotic liver disease and steatohepatitis (MASLD/MASH): A 2026 Update Environmental Determinants of Pediatric Obesity: An Epidemiological Review